York, PANCT02738047Now EnrollingIRB Ready

Pharmacogenomic Testing for Medication Management Clinical Trial in York, PA

Access cutting-edge pharmacogenomic testing for medication management treatment through this clinical trial at a research site in York. Study-provided care at no cost to qualified participants.

Sponsored by ClinLogic LLC

Quick Self-Assessment

See if you qualify for this York location

Preparing your pre-screening questions…

Expert Care in York

Access pharmacogenomic testing for medication management specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pharmacogenomic testing for medication management treatment provided free

Apply for This York Location

Check if you qualify for this pharmacogenomic testing for medication management clinical trial in York, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to York

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit York site if eligible
  4. 4Begin participation

About This Pharmacogenomic Testing for Medication Management Study in York

Pharmocogenomic test assessment in the medication regimen and disease management for patients under drugs known with genetic variation.

Sponsor: ClinLogic LLC

Who Can Participate

Inclusion Criteria

Patients may be included in the Study if they meet all of the following inclusion criteria:
Male or female patients of 25 years of age or older who are able to give their written Informed Consent to participate in a Clinical Study based on voluntary agreement with a thorough explanation of the patient's participation will be provided to them.
Patient underwent PGx testing for alleles appropriate to the target drugs within the prior 120 days ("index PGx test assessment");
Patient was receiving at least one medication known to be associated with allelic variation at the time of the ("index PGx test assessment"), including over-the- counter medications;
Patient has a history of at least one TDAE over the 24-month period preceding the PGx test assessment, or has experienced inadequate efficacy from a target drug.

Exclusion Criteria

Patients will be excluded from the Study if any of the following criteria apply:
Patient is currently hospitalized;
Patient's medical and medication history is unavailable over the 120-day period preceding the PGx test assessment;
Patient is unable to provide an accurate history due to mental Incapacity;
Patient is known to have undergone prior PGx testing for genes specific to the target drug(s), exclusive of the PGx test relating to this Study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in York?

Yes, this clinical trial (NCT02738047) has an active research site in York, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pharmacogenomic Testing for Medication Management Treatment Options in York, PA

If you're searching for pharmacogenomic testing for medication management treatment options in York, PA, this clinical trial (NCT02738047) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pharmacogenomic testing for medication management specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pharmacogenomic testing for medication management clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in York, PA

See all heart attack clinical trials recruiting in York — not just this study.

Browse Heart Attack Trials in York →

Browse More Trials by Condition

Heart Attack TrialsPulmonary Hypertension TrialsErectile Dysfunction TrialsInterstitial Cystitis TrialsMyocardial Infarction TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · York, PA